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Inhibition of apoptosis in rat mesangial cells by tissue inhibitor lation the net result of the imbalance between ECM
of metalloproteinase-1. synthesis and degradation [6–8].
Background. Tissue inhibitor of metalloproteinase-1 (TIMP-1)
Apoptosis and proliferation are mechanisms regulat-is an important inhibitor of extracellular matrix degradation.
ing the homeostasis of cell number [5]. It has been wellRecently, it was reported that TIMP-1 also could inhibit apo-
ptosis in B type lymphocyte. This study was designed to exam- accepted that over-proliferation of glomerular mesangial
ine the effects of TIMP-1 on mesangial cell apoptosis. cells can increase the accumulation of ECM promoting
Methods. The full-length cDNA of TIMP-1 was cloned and
progression of glomerulosclerosis [2]. It is now knownused to construct two recombinant vectors, TIMP-1S and
that glomerular mesangial cell apoptosis is the majorTIMP-1AS, encoding sense TIMP-1 and antisense TIMP-1,
respectively. The vectors were transfected into rat mesangial mechanism for resolution of glomerular hypercellularity
cells (RMC) and their expressions detected by Northern and in experimental glomerulonephritis [5, 9].
Western blotting. Apoptosis was induced by serum depriv-
Apart from apoptosis, ECM degradation is anotheration, and was monitored for DNA fragmentation by TUNEL
potential way for prevention of glomerulosclerosis. Com-assay and DNA laddering. In addition, the expression of endog-
enous TIMP-1, matrix metalloprotein-2 (MMP-2), and MMP-9, ponents of ECM can be degraded by matrix metallo-
as well as apoptosis-related genes Bcl-2 and Bax were investi- proteinases (MMPs), a group of structurally related zinc
gated.
metallo-enzymes [6]. MMP activities are negatively regu-Results. TIMP-1AS transfection induced a suppression of
lated by tissue inhibitors of metalloproteinases (TIMPs),TIMP-1 expression accompanied by an earlier onset of apo-
ptosis, and TIMP-1S transfection induced TIMP-1 over-expres- which bind to the active site of MMPs [10]. The balance
sion accompanied by a much later onset of apoptosis. A neutral- between MMPs and TIMPs determines the net activity of
izing antibody of TIMP-1 restored the sensitivity of TIMP-1S–
MMPs/TIMPs system [11]. Among the four TIMP genestransfected RMC to serum deprivation, but a synthetic matrix
reported to date, TIMP-1 was the first identified and hasmetalloproteinase inhibitor BB-94 did not influence the sensi-
tivity of TIMP-1S–transfected RMC to serum deprivation. Fi- been generally accepted as a key factor in ECM accumu-
nally, TIMP-1 over-expression inhibited the expression of Bax lation through its MMP inhibiting activity [12].
but with no effect on the expression of Bcl-2.
Interestingly, besides its MMP-inhibiting activity,Conclusion. TIMP-1 inhibits the serum deprivation-induced
TIMP-1 also has some MMP-independent effects, suchapoptosis in RMC, in which Bax might be involved.
as erythroid potentiating activity and cell growth pro-
moting activity in a wide range of cells [13, 14]. More
recently, another important novel function of TIMP-1Glomerulosclerosis, a process that leads to chronic
renal failure in a variety of human kidney disorders, has was discovered: it suppresses apoptosis in B cells [15].
been attributed to cell proliferation and extracellular It is of interest to know the potential role of TIMP-1
matrix (ECM) accumulation in the glomeruli [1–4]. Cell in the apoptosis of renal cells, as the balance between
proliferation is the net result of the imbalance between mesangial cell proliferation and apoptosis is a very im-
cell proliferation and apoptosis [5], while ECM accumu- portant event in many renal diseases and has been associ-
ated with the subsequent development of glomeruloscle-
rosis [16]. In this study, our aim was to determine whetherKey words: transfection, apoptosis, Bcl-2, Bax, cell death, extracellular
matrix, glomerulosclerosis. TIMP-1 contributes to apoptosis in rat mesangial cells
(RMC). We developed two transfected RMC models
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METHODS ment was cloned in the pCR2.1 vector (Invitrogen).
The plasmid was then purified and sequenced.Materials and reagents
The sense and antisense TIMP-1 recombinant vectors
All chemicals, unless otherwise stated, were obtained were constructed through standard procedures described
from Sigma Chemical Co. (St. Louis, MO, USA), and by Sambrook [24]. pCR2.1-TIMP-1 was digested by
were of the highest grade. TRIzol reagent was purchased EcoRI, and human TIMP-1 was inserted into the EcoRI
from Invitrogen Corp. (Carlsbad, CA, USA). Restriction site of a pcDNA3.1 expression vector. TIMP-1 orienta-
endonucleases and T4 ligase were purchased from Pro- tion was confirmed by digestion with EcoRI and AvaI
mega Ltd (Madison, WI, USA). The liposomal transfec- and the two expression vectors were obtained: TIMP-1S,
tion kit, DNA labeling kit, and apoptosis detection kit encoding the full-length TIMP-1 sense, and TIMP-1AS,
were from Boehringer Mannheim GMBH (Mannheim, encoding the full-length TIMP-1 antisense.
Germany). The Superscript RNase H-Reverse Tran-
Culture of RMCscriptase kit was from Gibco BRL, Life Technologies
(Paisley, Scotland, UK); the DNA purification kit was Rat mesangial cells were cultured from the glomerular
purchased from Qiagen Ltd., (Hilden, Germany). The explants of adult Wistar rat kidneys using standard tech-
pcDNA3.1 vector, TOPO10 competent E. coli cells, niques [25]. The cells were grown in RPMI 1640 medium
and pCRR2.1 vector were purchased from Invitrogen supplemented with 10% heat-inactivated fetal bovine
(Groningen, The Netherlands). Synthetic MMP inhibitor serum (FBS), 100 U/mL penicillin and 100 U/mL strep-
BB-94 was from British Biotech (Oxford, UK). The tomycin at 37C in a 5% humidified CO2 controlled at-
TIMP-1 antibody was from Oncogene Research Prod- mosphere. Cultured cells were characterized by their
ucts (Cambridge, MA, USA). typical stellate fusiform morphology, with positive stain-
ing for Thy1.1 antigen [26] and with resistance to thePrimers were based on the published sequences. The
toxic effects of D-valine [27]. RMC at passage 3 wasfollowing sequences were used. Human TIMP-1 sense,
used in this study.5-TTG AAT TCC CAC CAT GGC CCC CTT TGA
GCC-3, antisense, 5-GT GAATCC GCA GGA TTC
Transfection of TIMP-1S and TIMP-1ASAGG CTA TCT G-3 [17]. Rat TIMP-1 sense, 5-TTT
Rat mesangial cells were transfected with the emptyGCA TCT CTG GCC TCT-3, antisense, 5-AAT GAC
pcDNA3.1 control vector, TIMP-1S-pcDNA3.1, or TIMP-TGT CAC TCT CCA-5 [18]. Neor sense, 5-CAA GAT
1AS-pcDNA3.1 using DOTAP liposomal transfectionGGA TTG CAC GCA GCA GG-3, antisense, 5-CCC
reagent according to the Boehringer Mannheim proto-GCT CAG AAG AAC TCG TC-3 [19]. Rat Bcl-2 sense,
col. Briefly, the passage 3 RMC was cultured in RPMIACC GGG AGA TCG TGA TGA AGT-3, antisense,
1640 medium supplemented with 10% FBS, but with no5-CGG TTC AGG TAC TCA GTC ATC C-3 [20].
antibiotics addition. RMC was sub-cultured 18 hoursRat Bax sense, 5-GAC ACC TGA GCT GAC CTT
before transfection. The DOTAP/nucleic acid mixtureGG-3, antisense, 5-GA GGA AGT CCA GTG TCC
(5g DNA and 30L DOTAP) was added in the cultureAGC-3 [21]. Rat MMP-2 sense, 5-ATC TGG TGT
medium and incubated for six hours. The antibiotic freeCTC CCT TAC GG-3, antisense, 5-GTG CAG TGA
medium was replaced with complete medium and theTGT CCG ACA AC-3 [22]. Rat MMP-9 sense, 5-CAT
cells were incubated continuously. For stable transfec-GCG GCC GCC ATG AGT CC-3, antisense, 5-TTG
tion, the cells were subcultured 48 hours after trans-GAT CCA GTA TGT GAT GTT ATG ATG-3 [23].
fection, and then 0.4 mg/mL geneticin was added, after
which the cells were subsequently cultured in the pres-Cloning of human sense TIMP-1 and
ence of geneticin for 10 days. Monoclonal transfectedantisense TIMP-1
cell lines were obtained by using a cloning cylinder and
The full-length human TIMP-1cDNA was isolated by six cloned cell lines were established for the TIMP-1S
reverse transcription-polymerase chain reaction (RT- transfected RMC (TIMP-1S/MC), seven cloned cell lines
PCR). Briefly, total RNA was extracted from normal were established for TIMP-1AS (TIMP-1AS/MC), and
human kidney tissues using TRIzol reagent following three cloned cell lines were established for the vector
the protocol provided by Invitrogen Corp. First-strand transfected RMC (Vector/MC).
cDNA was synthesized using an oligo dT primer (Gibco
Genomic integration of human TIMP-1S andBRL), and PCR was carried out using VentR Taq poly-
TIMP-1AS in RMCsmerase (New England Biolabs, Beverly, MA, USA) at
94C for 15 seconds, 55C for 30 seconds and 72C for Genomic DNA was extracted from Vector/MC, TIMP-
60 seconds for the first 10 cycles, and then 94C for 15 1S/MC, TIMP-1AS/MC, or parental RMC. PCR for am-
seconds, 55C for 30 seconds, and 72C for two minutes plifying human TIMP-1 sense or TIMP-1 antisense was
performed at 94C for 30 seconds, 58C for one minute,for the secondary 15 cycles. The amplified DNA frag-
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and 72C for one minute for 30 cycles. PCR for PBS and then cultured in serum-free medium for 12 to
96 hours at 37C. Apoptosis also was induced in theseamplifying neor in pcDNA3 was performed at 94C for
serum-deprived cells pre-treated with anti-TIMP-1 mono-30 seconds, 61C for 45 seconds, and 72C for one minute,
clonal antibody (5g/mL; Oncogene Research Products,for 25 cycles.
Cambridge, MA, USA) or MMP inhibitor BB-94. Cells
RT-PCR and Northern blot analysis were monitored for apoptosis over extended periods of
time (12 to 96 hours), and optimal time points for detec-Reverse transcription-PCR was performed to evaluate
tion of apoptosis were determined.sense and antisense human TIMP-1 expression. Total RNA
Apoptosis was detected by DNA fragmentation usingwas extracted from the Vector/MC, TIMP-1S/MC, TIMP-
DNA laddering and TUNEL assay. For the DNA lad-1AS/MC, or parental RMC. For detecting antisense hu-
dering analysis, cells were harvested, and the DNA wasman TIMP-1 expression only, the antisense primer of hu-
extracted and run on a gel electrophoresis as previouslyman TIMP-1 was used as reverse transcription primer in
reported [28] TUNEL assay was performed as describedspecific synthesis of the first stand of antisense hTIMP-1
[29]. The results were analyzed under a light microscopecDNA. For detecting both sense and antisense hTIMP-1,
and documented on film.an oligo dT primer was used as reverse transcription
primer in synthesis of the first stand of hTIMP-1 cDNA.
RESULTSGAPDH primer was used as a control. RT-PCR was
performed at 94C for 30 seconds, 58C for one minute, Cloning and integration of TIMP-1 expression
and 72C for one minute, for 25 cycles. vectors in RMC
Northern blotting was performed to determined the The PCR-generated DNA encoding TIMP-1 was cloned
mRNA expressions of human TIMP-1S and AS, rat into pCR2.1 vector, confirmed by DNA sequencing,
TIMP-1, rat MMP-2, rat MMP-9, rat Bcl-2 and rat Bax. and subcloned into pcDNA3.1 vector. We constructed
A gel-electrophoresis was run with aliquots of RNA in two recombinant expression vectors: TIMP-1S, encoding
1% agarose-formaldehyde gels and later transferred to the TIMP-1 sense, and TIMP-1AS, encoding the TIMP-1
nylon membranes. These six cDNA probes were -32P antisense (Fig. 1A). TIMP-1 orientation in pcDNA3.1
randomly labeled for 24 hours and then hybridized. The was confirmed with EcoRI and AvaI digestion (Fig. 1B).
Northern blots were exposed to an x-ray film at 70C To examine whether the exogenous genes have been
for a suitable time. integrated into RMC, the genomic DNA was extracted
from the following four groups of cells, that is, Vector/
Western blot analysis for exogenous human TIMP-1 and MC, TIMP-1S/MC, TIMP-1AS/MC, or parental RMC,
endogenous rat TIMP-1 expression respectively. PCR was used to amplify the DNA of neor
and human TIMP-1. Our data showed that the exoge-Vector/MC, TIMP-1S/MC, TIMP-1AS/MC, or parental
nous neor in pcDNA3 vectors could be amplified fromRMC was washed with phosphate-buffered saline (PBS)
Vector/MC, TIMP-1S/MC, TIMP-1AS/MC, but not pa-for three times and incubated in lysis-buffer for 30 min-
rental RMC (Fig. 1C), while human TIMP-1 sense orutes. Supernatants were cleared of cell fragments by cen-
antisense could only be amplified from TIMP-1S/MC ortrifugation and protein concentration determined by Coo-
TIMP-1AS/MC, respectively (Fig. 1D).massie bright blue assay. The sample protein was mixed
with an equal volume of sample buffer, boiled for five RT-PCR, Northern blot and Western blot analyses of
minutes, electrophoresed on a 12% sodium dodecyl sul- overexpressed TIMP-1S and TIMP-1AS in RMCs
fate (SDS)-polyacrylamide gel for 60 minutes at room tem-
Using RT-PCR, the TIMP-1S-transfected cells were ex-perature, and transferred to nitrocellulose filters (Amer-
pressed human TIMP-1 sense transcripts while the TIMP-
sham Pharmacia Biotech, Castle Hill, NSW, Australia). 1AS-transfected cells produced TIMP-1 antisense RNA
The membrane was blocked with TTBS solution con- (Fig. 2).
taining 3% bovine serum albumin (BSA), incubated with Northern blot analysis (Fig. 3) showed that the TIMP-
mouse monoclonal antibodies against human TIMP-1 1S-transfected cells produced a high level of TIMP-1
dilution of 1:200 at room temperature for 60 minutes mRNA and Western blot analysis (Fig. 4) showed a high
and the binding was detected by the use of horseradish level of TIMP-1 protein expression. TIMP-1AS-trans-
peroxidase (HRP)-conjugated secondary antibody sys- fected cells expressed antisense TIMP-1 mRNA and no
tem. Also, goat anti-rat polyclonal antibody was used to protein expression.
detect the endogenous rat TIMP-1 protein expression.
Effect of over-expressed human TIMP-1S and
Apoptosis detection TIMP-1AS on endogenous rat TIMP-1,
MMP-2, and MMP-9The apoptosis of Vector/MC, TIMP-1S/MC, TIMP-
1AS/MC, or parental RMC was induced by serum depri- To investigate whether the transfected sense and anti-
sense human TIMP-1 could regulate the endogenous ratvation. Briefly, 5  105 cells were rinsed three times in
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Fig. 1. Construction of the sense and antisense tissue inhibitor of metalloproteinase-1 (TIMP-1) recombinant expression vectors and their DNA
integration into rat mesangial cells (RMC). (A) Scheme of sense TIMP-1 (TIMP-1S) and antisense TIMP-1 (TIMP-1AS) constructing that was
used to transfect to RMC. (B) Restriction map of recombinant plasmids; TIMP-1S and TIMP-1AS recombinant plasmids were digested with EcoRI
and AvaI. (C ) Integration of neor in clones of vector/MC, TIMP-1S/MC and TIMP-1AS/MC, while there is no integration of neor in parental cells,
as examined by PCR. (D) Integration of human TIMP-1 in clones of TIMP-1S/MC and TIMP-1 AS/MC, while there is no integration into parental
cells and vector/MC, as examined by PCR.
Fig. 2. Expression of exogenous human TIMP-1 sense and antisense
RNA detected by RT-PCR. Cellular RNA were extracted from the
following four group of cells: control parental cells (lane 2), vector/MC
(lane 3), TIMP-1S/MC (lane 4), and TIMP-1AS/MC (lane 5), reverse-
transcripted using an oligo (dT) primer (A), or downstream TIMP-1 Fig. 3. Expression of sense TIMP-1 and antisense TIMP-1 detected by
primer (B). TIMP-1S/MC express sense human TIMP-1, while TIMP-1 Northern blotting. Ten micrograms of cellular total RNA was extracted
AS/MC specifically express antisense TIMP-1. Lane 1 was the size marker. from clones of the following four group cells: control parental cells, vec-
tor/MC, TIMP-1S/MC, TIMP-1AS/MC. TIMP-1S/MC expressed sense
human TIMP-1 mRNA. TIMP-1AS/MC expressed antisense TIMP-1
mRNA. No TIMP-1 expression in parental cells and vector/MC was de-
TIMP-1, MMP-2, and MMP-9 levels in RMC, 30 g total tected. GAPDH served as an internal control for RNA expression.
RNA was analyzed by Northern blot hybridization. Rat
RMC normally produced weak but detectable levels of
rat TIMP-1 mRNA and protein. Human sense TIMP-1 did
Cells were observed periodically 12 to 96 hours afternot influence the expression of endogenous rat TIMP-1,
serum withdrawal. Apoptosis was assessed using DNAMMP-2 and MMP-9 mRNA. However, human antisense
degradation methods: TUNEL assay and DNA lad-TIMP-1 significantly reduced the endogenous rat TIMP-1
dering. The TIMP-1AS/MC underwent apoptosis 12mRNA and protein, with no affection on MMP-2 and
hours after serum deprivation, in contrast to parentalMMP-9 mRNA expression (Fig. 5).
RMC or Vector/MC, which only underwent apoptosis
Human TIMP-1 might protect RMC from apoptosis 48 hours after serum deprivation. TIMP-1S/MC did not
undergo apoptosis until four days later (Fig. 6).Apoptosis was induced with serum deprivation Vector/
MC, TIMP-1S/MC, TIMP-1AS/MC, or parental RMC. Using DNA laddering, we analyzed the DNA frag-
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Fig. 4. Expression of TIMP-1 protein detected by Western blotting.
Ten micrograms of protein from cells of the same four groups as in
Figure 3 were subjected to Western blot analysis using monoclonal
mouse anti-human TIMP-1 antibody. Numbers at the left correspond
to relative molecular weight of protein in kilodalton. Cells transfected
with sense TIMP-1 expressed the TIMP-1 protein. All the cell clones
for each group had similar results.
mentation of cells. TIMP-1AS/MC showed typical DNA
ladder 24 hours after serum starvation, parental cells and
Vector/MC showed DNA ladder 60 hours after serum
withdrawal, while TIMP-1S/MC still showed genomic
DNA (Fig. 7).
Effect of TIMP-1 antibody and BB-94 on apoptosis
To investigate the specificity of TIMP-1 anti-apoptotic
effect, we incubated parental RMC, vector/MC, TIMP-1S/
MC, and TIMP-1AS/MC with synthetic MMP inhibitor
BB-94 and with anti-TIMP-1 monoclonal antibody. Neu-
tralization of secreted TIMP-1 with TIMP-1 antibody
restored the sensitivity of TIMP-1S/MC to apoptosis in-
duced by serum deprivation (Fig. 8). Forty-eight hours
after cultured in serum-free medium, the percentage of Fig. 5. Effects of human sense and antisense TIMP-1 on the endoge-
nous rat TIMP-1, MMP-2, MMP-9 expression. (A) Thirty microgramsapoptotic cells was increased dramatically, from less than
of RNA extracted from control parental cells, vector/MC, TIMP-1S/MC,5% to 67%. Parental, vector/MC and TIMP-1AS/MC all
TIMP-1AS/MC were detected by Northern blot. Neither sense nor
had a slight increase in apoptotic cells at 24 hours after antisense human TIMP-1 transfection had any effects on the endoge-
nous rat MMP-2 and MMP-9 mRNA expression. Normally, there wasserum deprivation.
weak expression of endogenous TIMP-1 expression in RMC, transfec-In contrast, when parental RMC, Vector/MC, TIMP-
tion with sense human TIMP-1 had no effect on the endogenous TIMP-1
1S/MC, or TIMP-1AS/MC was treated with synthetic expression, while antisense human TIMP-1 transfection reduced the en-
dogenous rat TIMP-1 expression. (B) Fifty microliters of protein fromMMP inhibitor BB-94, no significant changes were ob-
control parental cells, vector/MC, TIMP-1S/MC, and TIMP-1AS/MCserved in apoptosis of these cells (data not shown), dem-
was subjected to Western blot analysis. Monoclonal goat anti-rat TIMP-1
onstrating that inhibition of MMP function did not affect was used for Western blot, the rat endogenous TIMP-1 was reduced
by antisense TIMP-1 transfection. Data are representative of experi-the effects of TIMP-1 on apoptosis in RMC induced by
ments with all of the cell clones from each group.serum deprivation. These results suggested that the anti-
apoptotic effect of TIMP-1 might be independent on its
inhibition on MMP function.
and down-regulation of TIMP-1 enhanced the expression
Effects of sense and antisense TIMP-1 on
of Bax. These results suggested that Bax might, at least
the expressions of apoptosis-related proteins
in part, be involved in the effect of TIMP-1 on apoptosis
Bcl-2 and Bax have been shown to be involved in the in RMC induced by serum deprivation (Fig. 9).
apoptosis of many kinds of cells [30]. Bcl-2 has been
shown to act as an inhibitor of apoptosis [31], while Bax
DISCUSSIONacts in opposition to Bcl-2 and overexpression of Bax
allows apoptosis to proceed [32]. To determine whether The present study did not investigate the effects of
TIMP-1 on metabolism of extracellular matrix, but foundBcl-2 or Bax are implicated in the cytoprotective effect
of TIMP-1, Northern hybridization was performed using that a high level of TIMP-1 expression was able to effec-
tively inhibit apoptosis of RMC in vitro, suggesting thatthese four groups of RMC to detect the expression of
Bcl-2 and Bax mRNA. Although all these cells expressed TIMP-1 might have a novel function of suppressing apo-
ptosis of RMC.Bcl-2, up-regulation and down-regulation of TIMP-1 had
no effect on the basal level of Bcl-2 expression. In contrast, Until now, it has been found that glomerular mesangial
cells, glomerular epithelial cells, proximal tubular epithe-up-regulation of TIMP-1 decreased the expression of Bax
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lial cells and fibroblasts in renal interstitium can express TIMP-1 could stably integrated into RMC. TIMP-1S/MC
could effectively express human TIMP-1 mRNA and pro-TIMP-1 [33, 34]. These data demonstrated that TIMP-1
is widely expressed in the kidney. TIMP-1 is a very impor- tein but have no effect on the endogenous rat TIMP-1
expression, while TIMP-1AS/MC could express anti-tant factor in renal diseases due to its role in MMP inhi-
bition. Many studies have reported that the expression of sense TIMP-1 and significantly down-regulate endoge-
nous rat TIMP-1 mRNA and protein expression. Hence,TIMP-1 is significantly increased in various rodent renal
fibrosis models [35–38], and clinical studies also have shown we established two contrasting RMC models with con-
stitutive over-expression or reduction of TIMP-1. In mostthat the expression of TIMP-1 in kidney was up-regu-
lated in patients with glomerulosclerosis [39]. Extracellu- prior studies, up-regulation or down-regulation of TIMP-1
in cultured cells was by the addition of exogenous rec-lar matrix accumulation and the apoptosis of mesangial
cell are two key events during the process of glomerular ombinant TIMP-1 or specific TIMP-1 antibodies into cul-
ture media. Our studies, however, focused on antisensediseases. The effects of TIMP-1 on ECM metabolism in
kidney has been well investigated, and it is clear now technology-based genetic modulation of cells of kidney,
which provided effective models for studying apoptosisthat TIMP-1 plays an important role in the development
of renal diseases by its ability to inhibit MMPs’ functions of RMC.
Our data demonstrated that the effect of inhibiting[1–4]. However, these studies of TIMP-1 in kidney had
focused on its role in inhibiting the ECM-degradating apoptosis of RMC might be a novel function of TIMP-1
in RMC, and that this effect was TIMP-1–specific andactivities of MMPs, and it is still unknown whether
TIMP-1 has other functions beyond blocking MMPs’ not secondary to MMPs’ inhibition. Firstly, neither sense
nor antisense TIMP-1 transfection affected the expres-activities in the kidney.
Studies have shown that TIMP-1 expression is associ- sion of rat MMP-2 or rat MMP-9, but both substantially
affected the apoptosis of RMC. Secondly, while syntheticated with resistance to apoptosis of Burkitt’s lymphoma
cell lines and human breast epithelial cells [40, 41]. The inhibitor BB-94, which can completely inhibit a wide spec-
trum of MMPs, had no effects on apoptosis of RMC,effects on apoptosis of other TIMPs also have been de-
scribed. TIMP-2 inhibits human melanoma cell invasion, neutralization of TIMP-1 with specific TIMP-1 antibody
apparently affect apoptosis of RMC. Reduced-alkylatedand TIMP-2 over-expression in tumor clones was found
to be more resistant to apoptosis than parental and con- TIMP-1, completely devoid of MMP inhibitory activity,
still resulted in apoptosis suppression [46]. The resulttrol melanoma cells [42]. Another report demonstrated
that TIMP-3 could promote apoptosis in rat vascular that the anti-apoptotic effect of TIMP-1 was independent
of its MMP inhibitory effect, which was inconsistent withsmooth muscle cells [43]. All these studies support the
idea that TIMPs can exert different functions, such as results of other studies, demonstrated that the cell growth
modulatory effect of TIMP-1 was unrelated to its MMPs’modulation of apoptosis and inhibition of MMPs’ activi-
ties. Apoptosis of glomerular mesangial cells is important inhibiting ability [47]. The above data suggest that in
addition to inhibiting MMPs’ activities, TIMP-1 also mayin the process of glomerulosclerosis. Although studies
have shown that TIMP-1 can inhibit apoptosis of B cells be able to regulate apoptosis of cells through another
pathway. Our data combining the results of other reports[15], it remains unknown whether TIMP-1 has any effect
on apoptosis of renal cells. Since glomerular mesangial suggest that TIMP-1 has the ability to directly regulate
apoptosis.cells play a key role in various renal diseases [2], it is
worthwhile to address the effect of TIMP-1 on apoptosis TUNEL and DNA laddering are two classical and
specific assays in detecting DNA fragmentation of apo-of mesangial cells. In present study, we found that high
level of intrinsic TIMP-1 expression effectively inhibited ptosis [48]. Since the aim of our study was to observe if
TIMP-1 could inhibit apoptosis of RMC, we examinedapoptosis in RMC in vitro, suggesting that one function
of TIMP-1 may be to suppress the apoptosis of RMC. the alterations of apoptotic cells’ morphology as well as
the specific DNA fragmentations with TUNEL and DNAAntisense oligos is believed to bind the endogenous
transcript with an ultimate down-regulation of the partic- laddering assays that showed enough data of apoptosis
to support our conclusion.ular protein level [44], and the role of antisense TIMP-1
in tumorigenics and metastasis has been reported [45, 46]. In the present study, apoptosis was investigated in
parental RMC, Vector/MC, TIMP-1S/MC, and TIMP-In the studies of gene transfection and transgenic mice,
it is a common and well-accepted method to transfect hu- 1AS/MC. It was shown that some TIMP-1AS/MC under-
went apoptosis after 12 hours culture in serum free mediaman genes into animal cells in vivo or in vitro. To provide
data for the exploration of role of TIMP-1 in human re- and almost all of the TIMP-1AS/MC underwent apopto-
sis after 24 hours. However, TIMP-1S/MC did not un-nal diseases, we cloned human TIMP-1, constructed two
contrasting recombinant expression vectors, TIMP-1S and dergo apoptosis until four days after serum deprivation.
The results disclosed that TIMP-1S was active inTIMP-1AS, and transfected them into RMC, the results
demonstrated that both sense and antisense human blocking apoptosis while TIMP-1AS promoted apoptosis
Lin et al: Apoptosis inhibition by TIMP-166
Fig. 6. (A) Effects of sense and antisense TIMP-1 on apoptosis in RMC induced by serum deprivation: TUNEL staining detecting the apoptosis.
(A, B, C, D) Twelve hours after culture in serum-free medium. (E, F, G, H) Twenty-four hours after culture in serum-free medium. (I, J, K)
Forty-eight hours after culture in serum-free medium. (A, E, I) Parental cells underwent apoptosis after 48 hours of serum deprivation. (B, F, J)
Vector/MC also underwent apoptosis after 48 hours of serum deprivation. (C, G, K) TIMP-1S/MC did not undergo apoptosis after 48 hours of
serum deprivation. (D, H) TIMP-1AS/MC began to undergo apoptosis after 12 hours of serum deprivation. The arrows indicated positive cells of
TUNEL staining.
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Fig. 8. Effect of TIMP-1 antibody on apoptosis in RMC induced by
serum deprivation (N  8). All the cells were treated with TIMP-1
neutralizing antibody before the induction of apoptosis by serum depri-
vation. *P  0.05 compared with the parental cell group and vector/MCFig. 6. (Continued). (B) Effects of sense and antisense TIMP-1 on
group. **P  0.001 compared with the parental cell group and vector/apoptosis in RMC induced by serum deprivation: Percentage of apo-
MC group. Symbols are: ( ) parental cells; ( ) vector/MC; () TIMP-ptotic as examined by TUNEL method. Symbols are: ( ) parental cells;
1S/MC, ( ) TIMP-1AS/MC.( ) vector/MC; ( ) TIMP-1S/MC; () TIMP-1AS/MC. **P  0.001
compared with the parental cell group and ††P  0.001 vector/MC
group. N  8 in each group.
Fig. 7. DNA laddering for apoptosis detection. Extracted genomic DNA
from parental, vector, TIMP-1S, and TIMP-1AS-transfected RMC 24
hours after serum deprivation. TIMP-1AS/MC showed typical DNA
ladder (A) and 60 hours later, parent cells and vector/MC showed DNA Fig. 9. Effects of sense and antisense TIMP-1 transfection on expres-
ladder, while in the meantime the TIMP-1S/MC still remained genomic sion of apoptotic protein. Twenty micrograms of cellular total RNA
DNA (B). was used for Northern blot analyses. Sense or antisense TIMP-1 trans-
fection had no effect on the expression of Bcl-2. However, up-regulation
of TIMP-1 decreased the expression of Bax, and down-regulation of
TIMP-1 enhanced Bax expression.
of RMC. As over-proliferation of RMC is a very impor-
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